Papers of the Week

March 30 - April 5, 2020

Aggressive Lymphoma Subtype Is A Risk Factor for Venous Thrombosis. Development of Lymphoma - Specific Venous Thrombosis Prediction Models.

Dharmavaram, G., Cao, S., Sundaram, S., Ayyapan, S., Boughan, K., Gallogly, M., Malek, E., Metheny, L., Tomlinson, B., Otegbeye, F., et al. (2020). Aggressive Lymphoma Subtype Is A Risk Factor for Venous Thrombosis. Development of Lymphoma - Specific Venous Thrombosis Prediction Models.Am J Hematol.

Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.

Ai, H., Qin, H., Li, J., Niu, C., Song, Z., Bao, Y., Sun, L., Zheng, L., and Li, Y. (2020). Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.Biochem Pharmacol113984.

Polarized sorting of Patched enables cytoneme-mediated Hedgehog reception in the Drosophila wing disc.

González-Méndez, L., Gradilla, A.-C., Sánchez-Hernández, D., Gonzalez, E., Aguirre-Tamaral, A., Jiménez-Jiménez, C., Guerra, M., Aguilar, G., Andrés, G., Falcon-Perez, J.M., et al. (2020). Polarized sorting of Patched enables cytoneme-mediated Hedgehog reception in the Drosophila wing disc.Embo Je103629.

A Multi-institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Christian, S., Arain, S., Patel, P., Khan, I., Calip, G.S., Agrawal, V., Sweiss, K., Griffin, S., Cahill, K., Konig, H., et al. (2020). A Multi-institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.Am J Hematol.